艾媒咨询｜2024年中国香港身份规划服务市场发展研究报告

中国香港正在面临劳动人口减少及产业升级挑战，身份规划服务市场呈现显著增长态势。2023年，通过各个人才引进计划，香港吸引了超过22万份新申请，其中约13.5万宗获得批准，获批率达61.3%，揭示了身份规划服务需求的强劲增长。iiMedia Research（艾媒咨询）的调研指出，该市场的主要客户群体为高学历、高收入的中青年人士，多数拥有学龄子女，其子女的年龄段大多集中在幼儿园和小学阶段。在选择服务时，客户最重视机构的专业性（61.6%）、成功案例（54.4%），以及“一站式”服务的便捷性（40.2%）。市场正向综合服务模式转变，服务机构正致力于提供涵盖税务规划、财富管理、子女教育等在内的全方位配套服务，实现真正意义上的“一站式”服务体验，推动行业服务标准升级。
Hong Kong, China, is facing the challenges of declining labor force and industrial upgrading, and the identity planning service market is showing significant growth. In 2023, Hong Kong attracted more than 220,000 new applications through various talent introduction schemes, of which about 135,000 were approved, with an approval rate of 61.3%, revealing a strong growth in demand for identity planning services. According to iiMedia Research, the main customer groups in this market are young and middle-aged people with high education and high incomes, most of whom have school-age children, and most of their children are concentrated in kindergarten and primary school. When choosing services, clients value the professionalism of the institution (61.6%), successful cases (54.4%), and the convenience of "one-stop" service (40.2%). The market is changing to a comprehensive service model, and service providers are committed to providing a full range of supporting services covering tax planning, wealth management, children's education, etc., to achieve a truly "one-stop" service experience and promote the upgrading of industry service standards.

艾媒咨询｜2022-2023年中国医美器械产业运行及投资决策分析报告

近两年来，光电美容仪器在生活美容领域逐步普及，而且微创和无创治疗已是国内医疗美容的发展趋势。在过去几年内，非手术治疗量在国内急速增长，激光抗衰老、紧肤、提升、祛皱、各种无创、微创光疗美容等也为普通消费者所接受，客户年龄广谱化日益明显，医疗美容激光这一类非介入式疗法或微创疗法将迎来可观的发展前景。

艾媒咨询｜2022年中国家用学习打印机创新趋势研究报告

随着疫情防控常态化和“双减”政策落地，居家学习上网课的场景增多，促使家用打印机需求激增；传统打印机的硬件痛点突出，而学习群体对产品和服务有迭代升级需求,中国家用打印机行业迎来需求增长和消费升级的机遇。数据显示，2021年中国打印机市场规模为352.1亿元，其中家用打印机市场规模为33.8亿元。

联赢激光2021年第三季度报告

艾媒咨询｜2021年中国美容美发行业投资机遇及总体趋势研究报告

数据显示，2015-2021年中国美容美发行业市场规模复合增长率为4.0%，2021年市场规模为3863亿元。随着国民生活水平的提高以及对生活品质的不断追求，美容美发业的消费需求旺盛，上下游产业和新兴业态快速发展，预估2022年中国美容美发行业市场规模将突破4000亿元。且值得注意的是，在备案完善、监督加强及违法经营成本提升的背景下，中国化妆品行业将加速整顿，有效保障产品安全及其功效的稳定性，具有较强研发实力的品牌有望占据更大的市场份额。随着新消费群体逐渐成为购买主力，不能快速响应市场的品牌面临淘汰，大规模企业兼并即将到来。
According to the data, the compound growth rate of the market scale of China's beauty salon industry from 2015 to 2021 was 4.0%, and the market scale in 2021 was 386.3 billion yuan. With the improvement of national living standards and the continuous pursuit of quality of life, the consumption demand of beauty salon industry is strong, and the upstream and downstream industries and emerging business forms are developing rapidly. It is estimated that the market scale of China's beauty salon industry will exceed 400 billion yuan in 2022. It is worth noting that under the background of perfect filing, strengthened supervision and increased illegal operating costs, China's cosmetics industry will accelerate the rectification and effectively ensure the stability of product safety and efficacy. Brands with strong R & D strength are expected to occupy a larger market share. As new consumer groups gradually become the main force of purchase, brands that cannot respond quickly to the market are facing elimination, and large-scale enterprise mergers are coming.

艾媒咨询|2021年中国互联网医院行业发展研究报告

本报告涉及的案例/品牌/企业：医联，京东健康，好大夫

随着《健康中国2030规划纲要》、“互联网+医疗健康”的国家倡导和执行方针落实，中国互联网医院的数量在2015-2020年五年间增长近1000家，2021年进入稳定上升期。iMedia Research(艾媒咨询)数据显示，自2018年起，中国互联网医院行业进入以医院主导的互联网医院占多数的发展状态。医院主导和企业主导的互联网医院各有不同竞争优势，面对国家的规范政策和市场需求增长，通过差异化定位和院企合作能有效提升各方效益。
With the implementation of the national plan for health China 2030 and Internet plus medical health, the number of China's Internet hospitals increased by nearly 1000 in 2015-2020 years and five years, and entered a stable rise in 2021. According to the data of imedia research, since 2018, China's Internet hospital industry has entered a development state in which hospital led Internet hospitals account for the majority. Hospital led and enterprise led Internet hospitals have different competitive advantages. In the face of national normative policies and market demand growth, the benefits of all parties can be effectively improved through differentiated positioning and hospital enterprise cooperation.

艾媒咨询|2021-2022年中国医美器械产业运行及投资决策分析报告

本报告研究涉及企业/品牌/案例：科医人，复星医药，奇致激光，半岛医疗

伴随着医美市场规模的持续扩大，中国医美器械行业发展前景可期。数据显示，预计2021年中国医美器械市场规模将超过500亿元，同比增长27.8%。从细分赛道来看，近年来，微创和无创已逐渐成为医疗美容的趋势，这就推动了以激光、超声波等能量源为代表的光电类医美器械的发展。从市场格局来看，中国正规医美机构设备的市场份额80%是进口品牌，且中高端市场被飞顿、塞诺龙等海外龙头企业占领。为了改变这一局面，国家及地方先后出台政策鼓励本土医美器械品牌的发展，同时，国有品牌也通过加大自主研发投入和投资并购来扩大市场份额，未来随着下游扩张、需求渗透、技术更新等因素有望加速进口替代。
With the continuous expansion of the medical beauty market, the development prospect of the medical beauty equipment industry in China is promising. According to the data, it is estimated that in 2021, the market size of medical devices in China will exceed 50 billion yuan, with a year-on-year growth of 27.8%. From the perspective of subdivision, in recent years, minimally invasive and non-invasive have gradually become the trend of medical beauty, which promotes the development of photoelectric medical beauty devices represented by laser, ultrasonic and other energy sources. From the perspective of market structure, 80% of the market share of China's regular medical and beauty institutions' equipment is imported brands, and the medium and high-end market is occupied by overseas leading enterprises such as feton and sinolon. In order to change this situation, the state and local governments have successively issued policies to encourage the development of local medical and beauty equipment brands. At the same time, the state-owned brands also expand their market share by increasing independent R & D investment and investment in M & A. in the future, with the downstream expansion, demand penetration, technology update and other factors, it is expected to accelerate the import substitution.

艾媒咨询|2021年中国轻医美行业研究及产业链分析报告

本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物

数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization.

艾媒咨询|2021年第一季度中国潮玩行业发展现状及市场调研分析报告

本报告研究涉及企业/品牌/案例：泡泡玛特,Sanrio,奥飞娱乐,乐高,52Toys,金运激光

2021年2月26日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research (艾媒咨询) 发布《2021年第一季度中国潮玩行业发展现状及市场调研分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对中国的潮玩进行了全面的分析，并且具体针对盲盒、手办、模型三大细分领域进行深度调研分析，结合用户调研数据对潮玩行业发展及进入提出新思路。

艾媒报告|2019-2020中国费控报销行业研究报告

本报告研究涉及企业/品牌/案例：汇联易,易快报,分贝通。
2019年中国费控报销行业受益于电子发票相关政策红利，增长强劲。iiMedia Research（艾媒咨询）数据显示，2019市场营收规模约为7.5亿元，增速达76.1%。艾媒咨询分析师认为，中国费控报销行业仍处在发展起步阶段，且企业费控报销具有刚需属性，在经济下行压力下，企业数字化转型动力日趋强烈，叠加电子发票的普及推广，费控报销产品有望加速渗透，推动市场规模持续增长。从市场用户角度来看，职场人群费用报销痛点显著，89.1%受访者认为手工报销模式亟待改革。对于能够有效解决职场人士报销痛点，帮助企业实现费用管控的费控报销产品，市场认知度普遍偏低，表示对这类产品不了解的受访者超过半数。艾媒咨询分析师认为，当前政策、技术、资本、市场环境对费控报销行业释放出越来越多的积极信号，行业发展环境日益向好，随着企业对数字化认知度逐步加深，费控报销行业有望迎来爆发增长，中国本土费控报销品牌也将迅速崛起。

　　In 2019, China's expense control reimbursement industry benefited from the policy dividend related to electronic invoice, with strong growth. According to iiMedia research, the market revenue scale in 2019 is about 750 million yuan, with a growth rate of 76.1%. iiMedia consulting analysts believe that China's expense control reimbursement industry is still in the initial stage of development, and the enterprise's expense control reimbursement has the property of rigid demand. Under the downward pressure of the economy, the enterprise's digital transformation momentum is increasingly strong. With the popularization and promotion of electronic invoice, the expense control reimbursement products are expected to accelerate the penetration and promote the continuous growth of market scale. From the perspective of market users, the cost reimbursement pain point of workplace population is significant, 89.1% of respondents think that the manual reimbursement mode to be reformed. For the cost control reimbursement products that can effectively solve the pain points of reimbursement for professionals and help enterprises achieve cost control, the market awareness is generally low, and more than half of the respondents said they did not know about such products. iiMedia consulting analysts believe that the current policy, technology, capital and market environment have released more and more positive signals to the expense control reimbursement industry, and the industry development environment is becoming better and better. With the gradual deepening of the digital awareness of enterprises, the expense control reimbursement industry is expected to usher in an explosion and growth, and the domestic expense control reimbursement brands will also rise rapidly.